LONDON - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.
LONDON - Reckitt Benckiser plans to spin off its heroin-addiction treatment in the next 12 months as sales slide under pressure from rival copycat versions of the drug. | Video
ZURICH - Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease.
WASHINGTON - U.S. lawmakers on Monday said they were expanding their investigation of federal biosecurity lapses including problems at the Centers for Disease Control and Prevention that led to the mishandling of anthrax and bird flu pathogens.
- Shares of AcelRx Pharmaceuticals Inc plunged almost 40 percent after the U.S. Food and Drug Administration rejected its pain treatment late on Friday.
FREETOWN - Sierra Leone's president visited the epicenter of an Ebola outbreak on Monday as West African leaders stepped up efforts to contain the spread of the deadly virus.
NEW YORK (Reuters Health) - Packed lunches that children bring from home are often missing the vegetables, milk and other healthy items recommended by dietary guidelines, says a new study.
LAGOS - The Nigerian city of Lagos shut down and quarantined on Monday a hospital where a man died of Ebola, the first recorded case of the highly infectious disease in Africa's most populous country.
ORLANDO Fla. - Support for legalizing medical marijuana in Florida is holding steady at 88 percent despite weeks of vigorous campaigning by opponents ahead of a November referendum on the issue, a poll released on Monday showed.
TEL AVIV - LabStyle Innovations Corp said on Monday it has received approval from Israel's Ministry of Health to sell its Dario smart meter for diabetes in Israel.
Video: Health Reform Watch
A series that looks at all facets of cancer, written by Debra Sherman, a lung cancer patient who succumbed to the disease on April 22, 2014. Debra covered the health beat for Reuters for more than a decade and drew on her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article